Contemporary Oncology

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

IMPACT FACTOR

2.9

MNiSW

Indexed in:

ESCI

Web of Science
Clarivate Analytics

JCI

0.24

Journal Citation Indicator

CiteScore 2023

3.1

Join us at Facebook!

1/2022
vol. 26

Review paper

Oxidative stress in melanogenesis and melanoma development

Kacper Kamiński, Urszula Kazimierczak, Tomasz Kolenda

Contemp Oncol (Pozn) 2022; 26 (1): 1–7

Online publish date: 2022-02-04

DOI : https://doi.org/10.5114/wo.2021.112447

Abstract Full text

Review paper

Research highlights on contributions of mitochondrial DNA microsatellite instability in solid cancers – an overview

Abdul Aziz Mohamed Yusoff, Siti Muslihah Abd Radzak, Siti Zulaikha Nashwa Mohd Khair

Contemp Oncol (Pozn) 2022; 26 (1): 8–26

Online publish date: 2022-03-30

DOI : https://doi.org/10.5114/wo.2022.115674

Abstract Full text

Original paper

Soluble B7H3 level in breast cancer and its relationship with clinicopathological variables and T-cell infiltration

Okan Avci, Eyyup Çavdar, Yakup İriağaç, Kubilay Karaboyun, Aliye Çelikkol, Tuğba İlkem Kurtoğlu Özçağlaya, Meltem Öznur, Sibel Özkan Gürdal, Erdoğan Selçuk Şeber

Contemp Oncol (Pozn) 2022; 26 (1): 27–31

Online publish date: 2022-02-11

DOI : https://doi.org/10.5114/wo.2022.113502

Abstract Full text

Original paper

Bevacizumab in metastatic colorectal cancer in a real-life setting – toxicity profile, survival outcomes, and impact of tumor sidedness

Hind Chibani, Khalid El Bairi, Ouissam Al Jarroudi, Said Afqir

Contemp Oncol (Pozn) 2022; 26 (1): 32–39

Online publish date: 2022-03-18

DOI : https://doi.org/10.5114/wo.2022.114678

Abstract Full text

Original paper

Gut microbiome as a potential biomarker of cancer risk in inflammatory bowel disease

Ryan Lane Jones

Contemp Oncol (Pozn) 2022; 26 (1): 40–43

Online publish date: 2022-03-16

DOI : https://doi.org/10.5114/wo.2022.114537

Abstract Full text

Original paper

Patient satisfaction and cost analysis of telehealth delivered by allied health oncology clinicians

Emma Charters, Maite J. Khom, Jacqueline Baker, Toni Lindsay

Contemp Oncol (Pozn) 2022; 26 (1): 44–48

Online publish date: 2022-03-29

DOI : https://doi.org/10.5114/wo.2022.115047

Abstract Full text

Original paper

Prognostic values of myeloid differentiation factor 88 (MYD88) and transducin (β)-like receptor 1 (TBLR1) expression in tissues of diffuse large B-cell non-Hodgkin lymphoma patients – an immunohistochemical study

Asmaa Hussein Mohamed, Mariem A. Elfeky, Shereen Elshorbagy, Nabila Hefzi, Tamer Oraby, Waleed A. Abdelhady, Mahmoud Sharaf Eldein, Ahmed Embaby, Ehab M. Oraby

Contemp Oncol (Pozn) 2022; 26 (1): 49–58

Online publish date: 2022-03-30

DOI : https://doi.org/10.5114/wo.2022.115675

Abstract Full text

Original paper

Modern-era radiotherapy and ischaemic heart disease-related mortality outcomes in Asian breast-cancer patients

Ling Fung Nelson Yit, Choon Ta Ng, Fuh Yong Won, Zubin Master, Siqin Zhou, Wee Loon Ng

Contemp Oncol (Pozn) 2022; 26 (1): 59–68

Online publish date: 2022-03-30

DOI : https://doi.org/10.5114/wo.2022.115676

Abstract Full text

Original paper

Prognostic significance of lymphocyte-to-monocyte ratio in patients with classical Hodgkin lymphoma before and after receiving first-line chemotherapy

Heba F. Taha, Lamiaa Mahmoud Kamel, Ahmed Embaby, Lobna A. Abdelaziz

Contemp Oncol (Pozn) 2022; 26 (1): 69–77

Online publish date: 2022-03-30

DOI : https://doi.org/10.5114/wo.2022.115459

Abstract Full text

Original paper

Clinical significance of cytokeratin 19 and OCT4 as survival markers in non-metastatic and metastatic breast cancer patients

Lobna A. Abdelaziz, Huda F. Ebian, Ola A. Harb, Yousef Nosery, Heba F. Taha, Nashwa Nawar

Contemp Oncol (Pozn) 2022; 26 (1): 78–87

Online publish date: 2022-03-30

DOI : https://doi.org/10.5114/wo.2022.115678

Abstract Full text

Letter to the Editor

A long-term responding epidermal growth factor receptor mutated non-small cell lung cancer patient with extremely high mutation allele frequency

Kunihiko Miyazaki, Yoshiharu Sato, Hiroaki Satoh, Nobuyuki Hizawa

Contemp Oncol (Pozn) 2022; 26 (1): 88–89

Online publish date: 2022-03-30

DOI : https://doi.org/10.5114/wo.2022.115447

Abstract Full text